Verroken, A.; Favresse, J.; Anantharajah, A.; Rodriguez-Villalobos, H.; Wittebole, X.; Laterre, P.-F.
Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial. Antibiotics 2024, 13, 67.
https://doi.org/10.3390/antibiotics13010067
AMA Style
Verroken A, Favresse J, Anantharajah A, Rodriguez-Villalobos H, Wittebole X, Laterre P-F.
Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial. Antibiotics. 2024; 13(1):67.
https://doi.org/10.3390/antibiotics13010067
Chicago/Turabian Style
Verroken, Alexia, Julien Favresse, Ahalieyah Anantharajah, Hector Rodriguez-Villalobos, Xavier Wittebole, and Pierre-François Laterre.
2024. "Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial" Antibiotics 13, no. 1: 67.
https://doi.org/10.3390/antibiotics13010067
APA Style
Verroken, A., Favresse, J., Anantharajah, A., Rodriguez-Villalobos, H., Wittebole, X., & Laterre, P. -F.
(2024). Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial. Antibiotics, 13(1), 67.
https://doi.org/10.3390/antibiotics13010067
